Gyre Therapeutics
GYRE
GYRE
51 hedge funds and large institutions have $13.7M invested in Gyre Therapeutics in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
54% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 26
82% less capital invested
Capital invested by funds: $75.5M → $13.7M (-$61.8M)
Holders
51
Holding in Top 10
1
Calls
$435K
Puts
–
Top Buyers
| 1 | +$1.58M | |
| 2 | +$943K | |
| 3 | +$469K | |
| 4 |
Morgan Stanley
New York
|
+$399K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$301K |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$5.87M | |
| 3 | -$4.11M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$2.56M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.5M |